JAGX
Jaguar Animal Health Inc
NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY
$3.94
-9.32% today
Updated 2026-06-03
Market cap
$2.02M
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-695.50
Dividend yield
—
52W range
$3 – $137
Volume
0.3M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+4.5
Quality
C4.0
Profitability
C5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-18.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$262.50
+6562.44%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Free cash flow $8.80M — positive
+ Revenue growth 816.00% QoQ
+ Debt/equity -2.42x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -18.21 — distress zone
- Thin margins at -115.40%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $11.96M | $9.76M | $11.69M | $11.51M | $29.57M |
| Net income | $-47.45M | $-41.30M | $-38.49M | $-53.58M | $8.85M |
| EPS | — | — | — | — | $-695.50 |
| Free cash flow | $-34.78M | $-33.24M | $-29.61M | $5.77M | $8.80M |
| Profit margin | -396.91% | -423.11% | -329.30% | -465.42% | -115.40% |
Peer comparison
Smart narrative
Jaguar Animal Health Inc trades at $3.94. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -18.21, it sits in the distress. TTM revenue stands at $29.57M. with profit margins at -115.40%.
Frequently asked questions
What is Jaguar Animal Health Inc's stock price?
Jaguar Animal Health Inc (JAGX) trades at $3.94, on a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Jaguar Animal Health Inc overvalued?
Jaguar Animal Health Inc carries a Smart Value Score of 48/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Jaguar Animal Health Inc (JAGX)?
The 12-month analyst consensus target is $262.50, about 6562.4% above the current $3.94. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Jaguar Animal Health Inc's revenue?
Jaguar Animal Health Inc's trailing twelve-month revenue is $29.57M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Jaguar Animal Health Inc's Altman Z-Score is -18.21, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.07x
ROE-411.60%
Beta-0.10
50D MA$8.59
200D MA$37.40
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—